Synchronous liver metastasis in colorectal cancer in Sri Lanka.

Objective To assess the incidence of synchronous colorectal liver metastasis in patients referred to a tertiary referral center in Sri Lanka and to evaluate the differences in the clinicopathological features of patients with and without synchronous metastasis. Methods Records of 438 patients were retrospectively analyzed. Patients were classified into metastatic group (n=34, 8%) and non metastastatic group (n=404, 92%). In the two groups macroscopic features compared were: tumor size (2 cm, 2–5 cm, and >5 cm), site of primary tumor and side of liver involved. Carcinoembryonic antigen (CEA) levels were recorded. At microscopy, tumor differentiation, invasion and nodal status were evaluated. Results The rectum was the primary site of the tumor in a majority (60%) of patients. There was no difference in the distribution of the primary site and size of the tumor, pathological stage, lymphatic infiltration and the degree of tumor differentiation in two groups (p>0.05). Patients with metastasis had higher levels of CEA, higher frequency of vascular infiltration and N3 nodes involved (p<0.05). Conclusion The incidence of synchronous colorectal liver metastasis seems to be lower in our patients. Association of higher CEA level, advanced nodal stage and presence of vascular invasion needs to be further assessed with risk of developing metachronous liver metastasis.

Prevalence of colorectal cancer and survival in patients from the Gampaha District, North Colombo region.

INTRODUCTION: The prevalence and survival of colorectal cancer in Sri Lankans has not been previously reported. We did a retrospective and a prospective survey, in the region of North Colombo, Sri Lanka between 1992 and 2004. The aim was to study cancer burden, sites of colorectal cancer and survival after surgery. PATIENTS AND METHODS: The records of 175 patients with colorectal cancer between 1992 and 1997 in the selected region of were analysed retrospectively. A prospective study was performed in 220 new patients with colorectal cancer between 1996 and 2004. Data evaluated were demographics, tumour stage and survival. RESULTS: Between 1992 and 1997 the crude annual incidence of colorectal cancer was 1.9 per 100,000, which increased over the years. The current national crude annual incidence is 3.2 per 100,000 in women and 4.9 in men. Median age at presentation was 60 years with similar prevalence of cancer in men and women. In the entire group, 28% of cancers were in those less than 50 years old. Survival at 2 and 5 years was 69% and 52%. The majority of cancer related deaths were within the first 2 years after surgery. CONCLUSION: The burden of colorectal cancer in Sri Lanka is on the rise. Up to a third of cancers occur in those under 50 years, and the majority of cancers are in the rectum or rectosigmoid region. Flexible sigmoidoscopy offers a useful screening tool.

Biofeedback with and without surgery for fecal incontinence improves maximum squeeze pressure, saline retention capacity and quality of life.

INTRODUCTION: Fecal incontinence (FI) impairs quality of life. We performed an audit of biofeedback (BFB) in management of patients with FI. METHODS: Fifty patients (median [range] age 30 [4-77] years; 28 men) who received BFB for median (range) of 15 weeks (4-28), either postoperatively (n=39), or as the sole treatment (n=11) were evaluated. Cleveland continence score (0-good, 20-poor), anorectal manometry parameters, and patient satisfaction (assessed by Fecal Incontinence Quality of Life Scale [FIQLS]) were evaluated at baseline and after the BFB therapy in all patients. RESULTS: Continence scores improved after intervention. In the surgery + BFB group, mean (SD) continence scores baseline vs. postsurgery + BFB (post-treatment) were 18.2 (3.9) vs. 6 (5.9; p< 0.01). In the BFB alone group, scores were similar at baseline 11.7 (5.9) and 6.1 (5.2) post BFB (p=0.08). Maximum resting anal pressure (MRP) improved from preoperative 12.6 (9.8) mmHg to: vs. 21.1 (11.9) mmHg post-treatment (p< 0.01). In patients who received BFB alone, MRP did not change significantly (pre vs post BFB 22.9 (11.7) mmHg vs. 29.6 (12.1) mmHg [p=0.08]). Maximal squeeze pressure improved significantly (preoperative vs. post-treatment: 46.3 (41.2) mmHg vs. 78.3 (33.9) mmHg [p< 0.01]; pre vs. post BFB alone: 72.4 (34.8) mmHg vs. 114.5 (43.1) mmHg [p< 0.01]). In 29 patients (19 surgery + BFB; 10 BFB alone), maximal tolerable volume in saline continence improved from baseline 47.9 (27.4) mL to 152.6 (87) mL after surgery + BFB (p< 0.01); pre vs. post BFB: 98 mL (95.9) vs. 205 (134.3) p< 0.02]. There was significant improvement in all parameters of FIQLS in both groups: lifestyle (p< 0.02), coping/behavior (p< 0.02), depression/self perception (p< 0.02) and embarrassment (p< 0.02). CONCLUSION: BFB therapy with or without surgical reconstruction of the damaged anal sphincter improves maximum squeeze pressure, saline retention capacity, quality of life and is a useful first line treatment for fecal incontinence.